KYMR
Kymera Therapeutics, Inc.
Stock
$107.39−2.73 (−2.48%)Close Oct 2, 2026
- Net income, 2025
- −$311M
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| 2025 | −$311M | — |
| 2024 | −$224M | — |
| 2023 | −$147M | — |
| 2022 | −$155M | — |
| 2021 | −$100M | — |
| 2020 | −$46M | — |
| 2019 | −$41M | — |